About the role
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster.
As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers.
Job title - Study Start-Up Lead
Location - UK, Spain, Bulgaria or Poland (Remote)
Fully sponsor dedicated
Working fully embedded within a growing, top 5 Pharmaceutical company, you will be responsible for executing global SSU activities to ensure timely trial document and task completion to enable country HA (Health Authorities) and Ethics Committee submissions and site activation to meet ambitious recruitment plans.
What you will be doing:
Early Planning and Team Leadership:
Contributes SSU insights to the development of the trial Operational Execution Plan (OEP) and aligns the SSU plan and strategy accordingly as reflected in SSU systems, milestones and dashboards with Study Leader/Clinical Trial Team (CTT).
Configures and ensures proper trial-specific set-up of SSU systems (e.g., Expected Document Lists, eTMF, milestones, tasks, personnel, vendors, languages/translations, confirmed and back-up countries, CTMS (Clinical Trial Management System), enrollment plan, vendor management tool, site contracting and budgeting tool, ICF template tool, etc.)
Prepares global SSU planning and leads SSU Team (CTT sub-team) from kick-off through completion of SSU (all countries and 95% sites enrolling or as defined per trial)
Leads Global SSU Activation:
Ensures timely collection global trial level document readiness (including vendor and IMP (INVESTIGATIONAL MEDICINAL PRODUCT)) and collection into eTMF as necessary for country health authority and Ethics Committee submission and site activation.
Supports the Vendor Program Manager (VPM) as needed to ensure timely global vendor activation and HA submission documents.
Ensures Protocol and ICF (Informed Consent Form) global trial template is ready for country usage as necessary including translations.
Directs the Study Grants Expert for investigator grant plan/fair market value assessment initiation and finalization of country site budget and contract template readiness in conjunction with protocol timelines Global accountability of timelines, accuracy, and quality of global TMF (Trial Master File) documents in study start-up to ensure TMF inspection readiness.
You are:
Must have right to work in any of these countries - UK, Spain, Poland or Bulgaria
Must have relevant experience in a similar role, ideally within a senior SSU role
Must have experience working within either the Clinical Research, Biotech or Pharmaceutical industry
Be able to start a new role within 4-8 weeks (highly advantageous)
Employment with ICON is contingent upon having the legal right to work in the country where the role is based.
Rewards & Benefits
ICON offers a competitive and comprehensive total rewards package designed to support your health, wellbeing, and career development.
Benefits may include:
- Competitive base salary and performance related incentives
- Health and wellbeing programmes including medical, dental, and vision coverage where applicable
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes and wellbeing resources
- Learning and development opportunities through structured training and career pathways
Benefits may vary depending on role and location.
Visit our careers site to read more about the benefits ICON offers.
Inclusion and Accessibility
ICON is an equal opportunity employer. We are committed to building an inclusive and accessible workplace where everyone feels valued and supported.
If you require reasonable accommodations during the recruitment process, please let us know or submit a request here.
Are you a current ICON Employee? Please click here to apply
Aplyr's read
ICON plc is a leading global provider of outsourced services in the pharmaceutical industry, attracting professionals in clinical research and data management.
What's promising
- •ICON plc has a strong global presence, enhancing its ability to manage international clinical trials effectively.
- •The company offers diverse career opportunities across various roles in clinical research and data analysis.
- •ICON's focus on innovation in pharmaceutical services supports its competitive edge in the industry.
What to watch
- •The pharmaceutical industry is highly regulated, which may limit flexibility in project execution.
- •ICON's reliance on large pharmaceutical clients could pose risks if partnerships dissolve.
- •The competitive nature of the CRO market may pressure ICON to maintain cost efficiency.
Why ICON plc
- •ICON plc specializes in comprehensive outsourcing solutions, differentiating it from competitors with narrower service scopes.
- •The company's integration of technology in clinical trials offers a unique advantage in data management.
- •ICON's strategic acquisitions have expanded its capabilities and market reach significantly.
Aplyr’s read is generated by AI from public sources. Was it useful?
About ICON plc
ICON plc is a global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries.